Stock Research: Monash IVF Group

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Monash IVF Group

ASX:MVF AU000000MVF3
25
  • Value
    8
  • Growth
    15
  • Safety
    Safety
    97
  • Combined
    18
  • Sentiment
    50
  • 360° View
    360° View
    25
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Monash IVF Group Limited is an Australia-based company specializing in assisted reproductive services and women's imaging. Key businesses include Fertility Solutions, KL Fertility, Monash IVF, Monash IVF KPJ Johor, and Monash Ultrasound for Women. It operates in Australia and Southeast Asia. In the last fiscal year, the company had a market cap of $192 million, profits of $152 million, revenue of $170 million, and 997 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 25 (better than 25% compared with alternatives), overall professional sentiment and financial characteristics for the stock Monash IVF Group are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half the metrics below and half above average for Monash IVF Group. The consolidated Value Rank has an attractive rank of 97, which means that the share price of Monash IVF Group is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is lower than for 97% of alternative stocks in the same industry. The consolidated Sentiment Rank has a good rank of 50, which means that professional investors are more optimistic about the stock than for 50% of alternative investment opportunities. But the consolidated Growth Rank has a low rank of 15, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. The consolidated Safety Rank has a riskier rank of 8, meaning the company has a riskier financing structure than 92 comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
ASX 300
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 10-Sep-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
97 83 71 71
Growth
15 5 59 33
Safety
Safety
8 10 17 23
Sentiment
50 77 100 68
360° View
360° View
25 27 78 47
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
91 85 71 87
Opinions Change
5 50 95 50
Pro Holdings
n/a 33 85 4
Market Pulse
81 86 79 76
Sentiment
50 77 100 68
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
97 83 71 71
Growth
15 5 59 33
Safety Safety
8 10 17 23
Combined
18 14 40 26
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
87 77 71 73
Price vs. Earnings (P/E)
73 59 53 61
Price vs. Book (P/B)
75 52 53 65
Dividend Yield
94 96 92 86
Value
97 83 71 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
26 37 49 27
Profit Growth
4 39 71 39
Capital Growth
98 10 9 7
Stock Returns
3 15 83 99
Growth
15 5 59 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
17 27 36 54
Refinancing
6 6 12 10
Liquidity
27 27 31 27
Safety Safety
8 10 17 23

Similar Stocks

Discover high‑ranked alternatives to Monash IVF Group and broaden your portfolio horizons.

Nipro

TSE:8086
Country: Japan
Industry: Health Care Supplies
Size: Large
Full Stock Analysis

Alfresa Holdings

TSE:2784
Country: Japan
Industry: Health Care Distributors
Size: Large
Full Stock Analysis

Suncorp

ASX:SUN
Country: Australia
Industry: Property & Casualty Insurance
Size: Medium
Full Stock Analysis

Flight Centre Travel

ASX:FLT
Country: Australia
Industry: Hotels, Resorts & Cruise Lines
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.